US Food and Drug Administration Approval of New Drugs Based on Noninferiority Trials in Oncology: A Dangerous Precedent?

Persons

Aaron Seth Kesselheim

Venue / Journal

JAMA Oncol

Date

Wed, 05/01/2019 - 12:00

Additional Journal Information

5(5):607-608

Authors

Gyawali B, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/30920591